Choudhury, Parichita http://orcid.org/0000-0002-8750-1160
Scharf, Eugene L.
Paolini, Michael A. II
Graff-Radford, Jonathan
Alden, Eva C.
Machulda, Mary M.
Jones, David T.
Fields, Julie A.
Murray, Melissa E.
Graff-Radford, Neill R.
Constantopoulos, Eleni
Reichard, Ross R.
Knopman, David S.
Duffy, Joseph R.
Dickson, Dennis W.
Parisi, Joseph E.
Josephs, Keith A.
Petersen, Ronald C.
Boeve, Bradley F.
Funding for this research was provided by:
Alzheimer's Disease Research Center, Mayo Clinic (P30 AG016574)
Alzheimer Disease Research Center, Mayo Clinic (P50 AG062677)
Article History
Received: 7 April 2020
Revised: 13 May 2020
Accepted: 15 May 2020
First Online: 21 May 2020
Compliance with ethical standards
:
: Drs. Choudhury, Scharf, Jones, Duffy, Reichard, Alden, Paolini, Murray, Dickson and Parisi have no conflicts of interests or disclosures. Dr. J Graff-Radford receives research support from National Institute of Health. Dr. Duffy has no conflicts of interest. Ms. Constantopolous has no disclosures. Dr. Fields has no conflicts of interests. She receives research support from NIH. Dr. Machulda received research support from National Institute of Health and National Institute of Deafness and Other Communication Disorders. Dr. Josephs has no conflicts of interest. He receives research support from the National Institute of Health. Dr. Knopman served on a Data Safety Monitoring Board for the DIAN study. He serves on a Data Safety monitoring Board for a tau therapeutic for Biogen, but receives no personal compensation. He is an investigator in clinical trials sponsored by Biogen, Lilly Pharmaceuticals and the University of Southern California. He serves as a consultant for Samus Therapeutics, Third Rock and Alzeca Biosciences, but receives no personal compensation. He receives research support from the NIH. Dr. Petersen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche, Inc. Merck, Inc. Genentech, Inc. Biogen, Inc. Eisai, Inc. GE Healthcare. Dr. Petersen has received personal compensation in an editorial capacity for UpToDate. Dr. N Graff-Radford has received research support from Eli Lilly, Novartis, Biogen, and AbbVie. Dr. Boeve serves as an investigator for clinical trials sponsored by Biogen, Alector, and EIP Pharma. He receives royalties from the publication of a book entitled Behavioral Neurology of Dementia (Cambridge Medicine, 2009, 2017). He serves on the Scientific Advisory Board of the Tau Consortium. He receives research support from the NIH, the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program, the Little Family Foundation, and the Turner Family Foundation.
: The present study was approved by the Mayo Clinic Institutional Review Board.
: All patients and/or their proxies had provided written consent to the use of their medical records and tissue for research.